Altimmune Inc
ALT
Get informed when a big investor buys or sells
+ FollowMarket Cap$507.58M
Close$
$0.09
96.1% downside
Current Fair Value
96.1% downsideOvervalued by 96.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $507.58 Million |
|---|---|
| Enterprise Value | $480.27 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1 |
| Beta | 0.18 |
| Outstanding Shares | 185,443,736 |
Return
| Return on Equity | -19.35% |
|---|---|
| Return on Assets | -17.40% |
| Return on Invested Capital | -19.47% |
Valuation & Multiples
| P/E Ratio | -3.35 |
|---|---|
| PEG | -109.14 |
| Price to Sales | - |
| Price to Book Ratio | 1.18 |
| Enterprise Value to Revenue | 15492.68 |
| Enterprise Value to EBIT | -4.79 |
| Enterprise Value to Net Income | -6 |
| Total Debt to Enterprise | 0.07 |
| Debt to Equity | 0.08 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 11, 2026
EPS Estimate
$-0.14
Average shareholder expectationRevenue Estimate
$2,000
Average shareholder expectationNext Earnings Call
Expected Date
November 5, 2026
EPS Estimate
$-0.14
Average shareholder expectationRevenue Estimate
$1,750
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 18.53% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.00%▼ 121.06% |
|---|---|
| Total Invested | $7,919▼ 100.00% |
| Investors Holding | 4▼ 218.00% |
ESG Score
No data
About Altimmune Inc
CEO: Vipin Garg